Jonathan Hale Zippin, M.D., Ph.D., FAAD, is Vice Chair of Research, Director Contact, Occupational, and Photodermatitis Service, Associate Professor of Dermatology, Associate Professor of Pharmacology, Associate Attending Dermatologist, NewYork-Presbyterian Hospital, Department of Dermatology, Weill Cornell Medicine.
He attended the Rockefeller/Cornell/Sloan-Kettering Tri-Institutional MD/PhD program. He completed his general medicine internship at the Mount Sinai Hospital in New York City, followed by a residency in dermatology at the Weill Cornell Medical Center – NewYork Presbyterian Hospital.
For the past 18 years, he has helped to establish the role of distinct cAMP microdomains in mammalian cell biology and revealed new mechanisms in insulin release and cancer. For the past ten years, Dr. Zippin’s laboratory has been dedicated to understanding the role of cAMP microdomains in skin disease. Dr. Zippin has served as a consultant for numerous pharmaceutical companies including Pfizer and Cellgene. Dr. Zippin has published numerous peer-reviewed papers and book chapters and serves on the board of multiple scientific societies.